Method for assessing the efficacy of a TR1 cell therapy in a subject
AssigneeTxcell
InventorsArnaud Foussat, Brigitte Quatannens
Life of this patent
Estimating the term…
Abstract
A method for assessing whether a patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, includes: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from the patient; and comparing the antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment.
Claims11
A method for assessing whether a human patient subjected to an antigen-specific Tr1 cell therapy is responding to the treatment, said method comprising:
- determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from said patient,
- comparing said antigen-specific proliferation to a standard reference,
- thereby determining whether the patient is responding or not responding to the treatment.
A method for assessing whether a human patient suffering from a disease and subjected to an antigen-specific Tr1 cell therapy for the disease is responding to the treatment, said method comprising:
- determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from said patient,
- comparing said antigen-specific proliferation to a standard reference,
- thereby determining whether the patient is responding or not responding to the treatment.
Dependencies are inferred from the claim text.